Survival advantage of bevacizumab rechallenge in recurrent ovarian cancer regardless of platinum sensitivity
Year: 2025
Type: article
Study design: Observational Study
Source: Anti-Cancer Drugs
Authors: Ugur Ozberk, Selin Akturk Esen, Serhat Sekmek, Ismet Seven, Oznur Bal, Efnan Algin, Sebnem Yucel, Dogan Uncu
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7116842226